Keri Toner
7PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 24, 2025
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma.Keri Toner, Lindsay A Renfro, Hema Dave
|Jan 22, 2025
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.Lianna J Marks, Victor Ritter, Jennifer E Agrusa
|Jun 25, 2024
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas.Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini
|Jan 01, 2024
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.Birte Wistinghausen, Keri Toner, Donald A Barkauskas
|Nov 29, 2023
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma.Keri Toner, Carl E Allen, Shweta Jain
|Sep 08, 2021
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma.Hema Dave, Madeline Terpilowski, Mimi Mai
Pageof 2
Frequent Collaborators
2 joint publications
Hema Dave
1 joint publications
Catherine M Bollard
1 joint publications
Melanie Grant
1 joint publications
Reuven Schore
1 joint publications
Richard Ambinder
1 joint publications
Birte Wistinghausen
1 joint publications
Donald A Barkauskas
1 joint publications
Hannah Kinoshita
1 joint publications
Pamela Chansky
1 joint publications
Michelle L Hermiston
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)